This study therefore focused on CD8+ tumor-infiltrating lymphocytes (TIL), Ki-67 labeling index (LI), p53 nuclear expression and mitotic count (MC), all of which have been well investigated in other solid cancers as candidate prognostic markers in GBC. This evidence concerns the gene TP53 and neoplasm.